Microfluidics, along with Biotest & Research Center Pharmaceutical Engineering (RCPE), presented our recent webinar:
Comparing Biotest HSA & recombinant HSA to prepare Nano Albumin Bound (nab) paclitaxel using the Microfluidizer® technology.
https://t.co/tb6Xi1ShHk
Join our webinar:
Comparison of Biotest HSA & Recombinant HSA for the Preparation of Nano Albumin Bound (nab) Paclitaxel using Microfluidizer® Technology.
Feb. 23rd at 9:00 am (EST)
https://t.co/HqFYEQASNe
#Microfluidics#Biotest#RCPE
Nanoparticle Albumin Bound Technology for NAB-Paclitaxel Production - Comparison of Biotest HSA and Recombinant HSA for the Preparation of Nano Albumin Bound (nab)-Paclitaxel using Microfluidizer® Technology - read the study.
https://t.co/A2zPFxFsEp
Microfluidics was honored to volunteer @PineStreetInn.
"With a mission to end homelessness, Pine Street Inn is New England's leading provider of housing, shelter, street outreach and job training to homeless men and women in Greater Boston."
Thank you, Pine Street Inn!
CPHI Frankfurt is in full swing and our stand has been busy with lots of great conversations.
Our team of experts are at stand #91G13 to answer your nanotechnology questions.
If you can't make it to the show, don't worry - we're just a message away.
#Microfluidics#CPHI2022
We had the opportunity to speak with Dr. Gary Yalloway and Dr. Julia Vivian, Senior Scientists at @CEGX_news , The Protein Science Group. They explained to us how they will be using LM20 Microfluidizer® Processor.🥼🧪🧬
https://t.co/5hoeYcSmRI
Our Microfluidics Team is excited to be exhibiting at CPHI
1 - 3 November 2022 - Messe Frankfurt, Germany - at Stand # 91G13.
Learn about our latest innovations in high-shear fluid processing.
Book a meeting with our team at: https://t.co/lsCCMZla5N
#Microfluidics#CPHI
Benchtop, Pilot scale, Production & Biopharmaceutical (cGMP) Models
Each of our Microfluidizer® Processors deliver unrivalled results in uniform nanoemulsions, cell disruption & particle size reduction.
Visit stand #531 or click https://t.co/jtgyWGeczx
#AAPS#PHARMSCI360
Day 1 of #AAPS#PHARMSCI360 is underway!
Our M110P #Microfluidizer® is on display at Booth 529 and we are available to answer all of your questions!
Learn why #pharmaceutical companies trust Microfluidics for their nanotechnology solutions.
https://t.co/yuyM5KXOBh
Watch our webinar: A Scalable Solution for Next-Generation #RNATechnology & Delivery. Microfluidics, with Dr. Darrick Carter, presented HDT Bio's proprietary LION™ delivery and how it addresses stability issues and dosage coordination.
https://t.co/65sQz5FkBA
Join Us SEPT. 15th at 11:00 AM (EST) for our WEBINAR!
Our distinguished guest speaker, Chief Scientific Officer at HDT Bio Corp., Dr. Darrick Carter will present:
A Scalable Solution for Next-Generation RNA Technology and Delivery
https://t.co/IK73H7yWqA
#Microfluidics
A Scalable Solution for Next-Generation RNA Technology & Delivery
Register today to learn more about A Scalable Solution for Next-Generation RNA Technology & Delivery with the distinguished Dr. Darrick Carter of HDT Bio.
https://t.co/1vFBeS6cVw
Join Us Sept. 15th at 11:00 AM (EST)
Our distinguished guest speaker, Chief Scientific Officer at HDT Bio Corp., Dr. Darrick Carter will present:
A Scalable Solution for Next-Generation RNA Technology and Delivery
Register TODAY
https://t.co/yCKU3NDxOP
#NextGenRNATech
Microfluidizer® Technology: cGMP Technology for RNA Delivery
View Microfluidizer Technology: A cGMP Technology with Scale Up for Viral & Non-viral RNA Delivery Platforms presented at the 2022 RNA Therapeutics & Delivery U.S. Congress
https://t.co/zQdqNJhweX
Discover why top companies trust the Aftermarket service we offer - Microfluidics is proud to be known for providing exceptional Aftermarket service to each customer who invests in a Microfluidizer® processor.
https://t.co/yJyQUuguGF
The Return To #INTERPHEX
Microfluidics International Corporation was excited to participate in person at INTERPHEX 2022 after a nearly three-year absence. As part of IDEX MPT, Inc., Microfluidics returned to the Javits Center, in NYC, on May 24 – 26th.
https://t.co/0ZmYmxVOSI